These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15289319)

  • 41. Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.
    Krishnaswamy S; Mohammed AK; Tripathi G; Alokail MS; Al-Daghri NM
    BMC Cancer; 2017 Nov; 17(1):738. PubMed ID: 29121914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail.
    Grotegut S; von Schweinitz D; Christofori G; Lehembre F
    EMBO J; 2006 Aug; 25(15):3534-45. PubMed ID: 16858414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
    Kretschmann KL; Eyob H; Buys SS; Welm AL
    Curr Drug Targets; 2010 Sep; 11(9):1157-68. PubMed ID: 20545605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia promotes nuclear translocation and transcriptional function in the oncogenic tyrosine kinase RON.
    Chang HY; Liu HS; Lai MD; Tsai YS; Tzai TS; Cheng HL; Chow NH
    Cancer Res; 2014 Aug; 74(16):4549-62. PubMed ID: 24903148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.
    Wang MH; Lao WF; Wang D; Luo YL; Yao HP
    Cancer Biol Ther; 2007 Jul; 6(7):1121-9. PubMed ID: 17611409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter.
    Angeloni D; Danilkovitch-Miagkova A; Ivanova T; Braga E; Zabarovsky E; Lerman MI
    Oncogene; 2007 Jul; 26(31):4499-512. PubMed ID: 17297469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptor tyrosine kinase Ron is expressed in mouse reproductive tissues during embryo implantation and is important in trophoblast cell function.
    Hess KA; Waltz SE; Chan EL; Degen SJ
    Biol Reprod; 2003 Apr; 68(4):1267-75. PubMed ID: 12606483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer.
    Yu H; Yuan J; Xiao C; Qin Y
    Int J Mol Med; 2013 May; 31(5):1248-54. PubMed ID: 23483216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration.
    Jaquish DV; Yu PT; Shields DJ; French RP; Maruyama KP; Niessen S; Hoover H; A Cheresh D; Cravatt B; Lowy AM
    Carcinogenesis; 2011 Aug; 32(8):1151-6. PubMed ID: 21565828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression.
    Sullivan C; Brown NE; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
    Mol Cancer Res; 2020 Aug; 18(8):1244-1254. PubMed ID: 32439702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ron-receptor tyrosine kinase in tumorigenesis and metastasis.
    Leonis MA; Thobe MN; Waltz SE
    Future Oncol; 2007 Aug; 3(4):441-8. PubMed ID: 17661719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo.
    Chen YQ; Zhou YQ; Fisher JH; Wang MH
    Oncogene; 2002 Sep; 21(41):6382-6. PubMed ID: 12214279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ron receptor tyrosine kinase: a key regulator of inflammation and cancer progression.
    Wang X; Hankey PA
    Crit Rev Immunol; 2013; 33(6):549-74. PubMed ID: 24266348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.
    Côté M; Miller AD; Liu SL
    Biochem Biophys Res Commun; 2007 Aug; 360(1):219-25. PubMed ID: 17588532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Agonistic monoclonal antibodies potentiate tumorigenic and invasive activities of splicing variant of the RON receptor tyrosine kinase.
    Yao HP; Luo YL; Feng L; Cheng LF; Lu Y; Li W; Wang MH
    Cancer Biol Ther; 2006 Sep; 5(9):1179-86. PubMed ID: 16880737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial-mesenchymal transitions in cancer progression.
    Birchmeier C; Birchmeier W; Brand-Saberi B
    Acta Anat (Basel); 1996; 156(3):217-26. PubMed ID: 9124038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells.
    Liu HS; Hsu PY; Lai MD; Chang HY; Ho CL; Cheng HL; Chen HT; Lin YJ; Wu TJ; Tzai TS; Chow NH
    Carcinogenesis; 2010 Aug; 31(8):1456-64. PubMed ID: 20498137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.
    Faham N; Welm AL
    Cold Spring Harb Symp Quant Biol; 2016; 81():177-188. PubMed ID: 28057847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feline STK gene expression in mammary carcinomas.
    De Maria R; Maggiora P; Biolatti B; Prat M; Comoglio PM; Castagnaro M; Di Renzo MF
    Oncogene; 2002 Mar; 21(11):1785-90. PubMed ID: 11896610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RON-expressing MCF-10A breast epithelial cells exhibit alterations of hyaluronan expression, promoting RON-mediated early adhesion events.
    Feres KJ; Hayman MJ
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1604-9. PubMed ID: 20026054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.